Investor Home

Corporate Profile

Apricus is committed to developing novel therapies in areas of high unmet needs. We have disciplined leadership focused on execution and are driving near-term shareholder value through regulatory approval, commercialization and partnering initiatives.

Recent News

more >

Date

Title

12/14/18

Apricus Biosciences Adjourns Special Meeting of Stockholders to New Date

The Meeting Seeking Stockholder Approval for Proposed Merger with Seelos Therapeutics, Inc. Will Be Reconvened on January 4, 2019 SAN DIEGO, Dec. 14, 2018 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq: APRI) has today convened and adjourned its special meeting of stockholders in order to obtain specific stockholder approvals required pursuant to the terms of its merger agreement with Seelos Therapeutics, Inc. and the related securities purchase agreement with selected investors. T...

12/10/18

Apricus Biosciences Reminds Shareholders to Vote Before the Special Meeting on December 14, 2018

Seeking Shareholder Approval for Proposed Merger with Seelos Therapeutics, Inc. SAN DIEGO, Dec. 10, 2018 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq: APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, reminds shareholders to vote by proxy before the upcoming special stockholders meeting on December 14, 2018. Apricus is holding a special meeting of stockholders in order to obtain the stockholder approvals required pursuant to the terms o...

10/31/18

Apricus Biosciences Provides Corporate Update and Third Quarter 2018 Financial Results

Company Merger with Seelos Therapeutics, Inc. Expected to Close in Fourth Quarter 2018 Apricus Shareholders Expected to Own ~15% of Estimated $94 Million Combined Company Valuation at Closing SAN DIEGO, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company historically focused on seeking to advance innovative medicines in urology and rheumatology, today reported financial results for the third quarter and year-to-date for 2018 and provided a...

Event Calendar

more >

January 2019

Calendar Help

This calendar contains six months of past and future company related information, which may include press releases, SEC filings, calendar events and more. Dates containing information are indicated by a colored background. You may hover your mouse over a date that contains an event to reveal the event or events taking place on that day including a link to additional information. This calendar requires JavaScript to be installed and activated on your browser.

Calendar Icon Legend:

Analyst Meeting

Conference

Conference Presentation

Corporate Conference Call

Custom Events

Earnings Conference Call

Earnings Release

Financial Reports

Mergers & Acquisition Announcement

Guidance Announcement

Other Corporate

Sales Call/Presentation

Sales Release

Shareholders Meeting

News Release

SEC Filings

Presentations

52 Week High

‹

Today

›

-2

-1

01/04/19

425

Formats:

8-K

Formats:

SC 13G/A

Formats:

Receive E-mail Alerts

Sign up to receive e-mail alerts whenever Apricus Biosciences, Inc. posts new information to the site. Just enter your e-mail address and click Submit.

Investor Relations

Investor Contact